Rivaxa

Rivaxa Uses, Dosage, Side Effects, Food Interaction and all others data.

Rivaxa is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaxa does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.

Rivaxa is an anticoagulant which binds directly to factor Xa. Thereafter, it effectively blocks the amplification of the coagulation cascade, preventing the formation of thrombus. Rivaxa is a unqiue anticoagulant for two reasons. First of all, it is does not involve antithrombin III (ATIII) to exert its anticoagulant effects. Secondly, it is an oral agent whereas the widely used unfractionated heparin and low molecular weight heparins are for parenteral use only. Although the activated partial thromboplastin time (aPTT) and HepTest (a test developed to assay low molecular weight heparins) are prolonged in a dose-dependant manner, neither test is recommended for the assessment of the pharmacodynamic effects of rivaroxaban. Anti-Xa activity and inhibition of anti-Xa activity monitoring is also not recommended despite being influenced by rivaroxaban.

Trade Name Rivaxa
Availability Prescription only
Generic Rivaroxaban
Rivaroxaban Other Names Rivaroxaban
Related Drugs Xarelto, Praluent, Repatha, amlodipine, aspirin, propranolol, clopidogrel, Eliquis, warfarin, simvastatin
Weight 2.5mg, 10mg
Type Tablet
Formula C19H18ClN3O5S
Weight Average: 435.881
Monoisotopic: 435.065569098
Protein binding

Plasma protein binding is about 92% to 95%

Groups Approved
Therapeutic Class Oral Anti-coagulants
Manufacturer Abbott Healthcare Pvt Ltd, Square Pharmaceuticals Ltd
Available Country India, Bangladesh
Last Updated: September 19, 2023 at 7:00 am
Rivaxa
Rivaxa

Uses

Rivaxa 2.5 mg:

  • For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.

Rivaxa 10-20 mg:

  • To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
  • Deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE
  • For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery

Rivaxa is also used to associated treatment for these conditions: Cardiovascular Mortality, Deep Vein Thrombosis, Deep vein thrombosis recurrent, Myocardial Infarction, Pulmonary Embolism, Recurrent pulmonary embolism, Stroke, Systemic Embolism

How Rivaxa works

Rivaxa competitively inhibits free and clot bound factor Xa. Factor Xa is needed to activate prothrombin (factor II) to thrombin (factor IIa). Thrombin is a serine protease that is required to activate fibrinogen to fibrin, which is the loose meshwork that completes the clotting process. Since one molecule of factor Xa can generate more than 1000 molecules of thrombin, selective inhibitors of factor Xa are profoundly useful in terminating the amplification of thrombin generation. The action of rivaroxaban is irreversible.

Dosage

Rivaxa dosage

Rivaxa 2.5 mg:

The recommended dose is 2.5 mg twice daily. Patients should also take a daily dose of 75-100 mg Aspirin or a daily dose of 75-100 mg Aspirin in addition to either a daily dose of 75 mg clopidogrel or a standard daily dose of ticlopidine.

Rivaxa 10-20 mg:

Nonvalvular Atrial Fibrillation: For patients with Creatinin Clearance >50 mL/min: 20 mg orally, once daily with the evening meal. For patients with Creatinin Clearance 15-50 ml/min: 15 mg orally, once daily with the evening meal

Treatment of DVT & PE: 15 mg orally twice daily with food for the first 21 days for the initial treatment of acute DVT or PE. After the initial treatment period, 20 mg orally once daily with food for the remaining treatment

Prevention in the risk of recurrence of DVT and of PE: 20 mg once daily with food

Prophylaxis of DVT following Hip replacement surgery: 10 mg once daily for 35 days

Prophylaxis of DVT following knee replacement surgery: 10 mg once daily for 12 days

Side Effects

The most common adverse reaction is bleeding. Increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.

Toxicity

Excessive bleeding. Overdosages should be treated using activated charcoal and supportive measures such as mechanical compression and hemodynamic support. If bleeding is not controlled, the following procoagulants can be administered: activated prothrombin complex concentrate, prothrombin complex concentrate and recombinant factor VIIa. There is also a higher chance of post procedural hemorrhage compared to enoxaparin (1.55% vs. 1.39% respectively).

Precaution

Rivaxa can cause bleeding. Promptly evaluate signs and symptoms of blood loss. Rivaxa use not recommended in case of Prosthetic heart valves.

Interaction

CYP3A4, P-GP inhibitors and NSAIDs.

Food Interaction

  • Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.
  • Avoid St. John's Wort. Co-administration will decrease levels of this medication.
  • Take with food. Rivaxa 15-20mg dose should be taken with food as food significantly impacts the bioavailability at that dose.
  • Take with or without food. Rivaxa 10mg dose can be taken with or without food as it does not significantly impact the bioavailability at that dose.

Volume of Distribution

The steady state Vd is 50 L

Elimination Route

Following oral administration, rivaroxaban is rapidly absorbed and reaches peak plasma concentration in 2-4 hours. Bioavailability of the 10 mg dose is >80%. However, the 15-20 mg dose have a lower bioavailability if taken in the fasted state and consequently should be taken with food.

Half Life

The terminal half life is 5-9 hours in adults and 11-13 hours in the elderly.

Clearance

Systemic clearance is approximately 10 L/h, so rivaroxaban is considered a drug with low clearance. Renal clearance is ~3-4 L/h.

Elimination Route

Approximately two-thirds of rivaroxaban is excreted into urine (via active tubular secretion in which approximately 36% as unchanged drug and 30% as inactive metabolism). The remaining third of the administered dose is excreted via feces in which 7% is in the form of unchanged drug and 21% as inactive metabolites.

Pregnancy & Breastfeeding use

There are no adequate or well-controlled studies of Rivaxa in pregnant women, and dosing for pregnant women has not been established.

Safety and efficacy of Rivaxa have not been established in breast-feeding women

Contraindication

Active pathological bleeding & severe hypersensitivity reaction to Rivaxa

Storage Condition

Protect from light, store below 30° C. Keep out of reach of children.

Innovators Monograph

You find simplified version here Rivaxa

Rivaxa contains Rivaroxaban see full prescribing information from innovator Rivaxa Monograph, Rivaxa MSDS, Rivaxa FDA label

FAQ

What is Rivaxa used for?

Rivaxa is used to treat and prevent deep venous thrombosis , a condition in which harmful blood clots form in the blood vessels of the legs.

How safe is Rivaxa?

Rivaxa is safe to take for a long time. There do not seem to be any lasting harmful effects from taking it for many months and years.

How does Rivaxa work?

Rivaxa works by stopping a clotting factor called factor Xa from working. This thins your blood so it takes longer to clot.Rivaxa works within a few hours of taking it.

What are the common side effects of Rivaxa?

The common side effect of Rivaxa is bleeding more easily than normal, such as having nosebleeds, heavier periods, bleeding gums and bruising. It tends to happen in the first few weeks of treatment or if you're unwell. Always carry your anticoagulant alert card with you.

Is Rivaxa safe during pregnancy?

There are no controlled data in human pregnancy. This drug should be used during pregnancy only if the benefit outweighs the risk. Some authorities consider it contraindicated.

Is Rivaxa safe during breastfeeding?

exposure of Rivaxa via breastfed is seldom clinically relevant for the infant. A pediatric assessment of the infant found no detectable drug-related adverse effects.

Can I drink alcohol with Rivaxa?

The alcohol can increase Rivaxa effect and make you more likely to bleed.

When should I take Rivaxa?

It's usual to take Rivaxa once or twice a day. Take Rivaxa just after you have eaten a meal or snack. It's important to take it with food to help your body absorb the whole dose.

Should I take Rivaxa in morning or at night?

Once a day with your evening meal. Take your next dose at your regularly scheduled time.

Does Rivaxa cause insomnia?

It's possible to have insomnia while you're taking Rivaxa.

Can Rivaxa cause kidney problems?

One of the severe side effects of Rivaxa  is that it can cause acute kidney injuries. In the past few years, medical researchers have recognized a new type of acute kidney injury: Anticoagulant-related nephropathy.

How long does Rivaxa stay in my system?

Rivaxa takes 2–4 hours for it to reach its full blood-thinning effect, and it leaves your system more quickly than warfarin—typically in about 24 hours.

Can I just stop taking Rivaxa?

Do not stop taking Rivaxa without talking to your doctor. If you stop taking Rivaxa, the rate at which your blood clots will return to what it was before you started taking it, usually within a day or two of stopping.

Can I take Rivaxa every other day?

You can take your dose at any time of day.

Who should not take Rivaxa?

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Can Rivaxa cause liver problems?

Rivaxa has been shown to cause liver damage, particularly in men over 60 who have been on the medication for six months or more. Anyone who has taken Xarelto for any period of time is urged to get their liver function tested.

What happens if I overdose on Rivaxa?

Seek emergency medical attention.Overdose may cause excessive bleeding.


*** Taking medicines without doctor's advice can cause long-term problems.
Share